About Vanadis® NIPT
Vanadis® NIPT is a high-precision non-invasive prenatal assay designed to accurately screen for the three most common chromosomal anueploidy syndromes (Trisomy 21, 18, and 13). Utilizing the PerkinElmer Vanadis® system, this laboratory developed test was designed to offer an affordable testing option that can deliver accurate and reliable results to more women than ever before.
Features of Vanadis® NIPT
Accurate screening for the most common aneuploidies: Trisomy 21, 18 and 13
Optional selection of fetal sex determination
Low no-call rate provided by high-precision technology
Benefits of Vanadis® NIPT
High-precision test: Utilizing an innovative cell-free DNA testing technology, Vanadis® NIPT performs with high-precision even for samples with low fetal fractions.
Simple, Safe and Convenient: Reliable results delivered from a single blood draw as early as 10 weeks gestation.
Fast Turn-Around-Time: Results are available in an average of 5-7 days.
Increased Accessibility to Testing: Vanadis® NIPT is performed without the expenses of PCR or complex bioinformatics, allowing for an affordable option for accurate aneuploidy screening for more women.